| 产品编号 | CFN93161 | |
| CAS编号 | 116782-73-1 | |
| 分子式 = 分子量 | C34H52O9 = 604.78 | |
| 产品纯度 | >=98% | |
| 物理属性 | Powder | |
| 化合物类型 | Steroids | |
| 植物来源 | The roots of Periploca sepium Bge. | |
| ChemFaces的产品在影响因子大于5的优秀和顶级科学期刊中被引用 | ||
| 产品名称 | 产品编号 | CAS编号 | 包装 | QQ客服 |
| 北五加皮苷M | CFN93161 | 116782-73-1 | 1mg | QQ客服:1413575084 |
| 北五加皮苷M | CFN93161 | 116782-73-1 | 5mg | QQ客服:1413575084 |
| 北五加皮苷M | CFN93161 | 116782-73-1 | 10mg | QQ客服:1413575084 |
| 北五加皮苷M | CFN93161 | 116782-73-1 | 20mg | QQ客服:1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)| Description: | Periplocoside M possesses observably antitumor activity against SMMC-7721( IC 50=12.9 ng/L),Hela( IC 50=8.63 ng/L) and MCF-7( IC 50=18.5 ng/L) cancer cell lines. | |||
| In vitro: |
|
| 1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
| 1 mM | 1.6535 mL | 8.2675 mL | 16.5349 mL | 33.0699 mL | 41.3373 mL |
| 5 mM | 0.3307 mL | 1.6535 mL | 3.307 mL | 6.614 mL | 8.2675 mL |
| 10 mM | 0.1653 mL | 0.8267 mL | 1.6535 mL | 3.307 mL | 4.1337 mL |
| 50 mM | 0.0331 mL | 0.1653 mL | 0.3307 mL | 0.6614 mL | 0.8267 mL |
| 100 mM | 0.0165 mL | 0.0827 mL | 0.1653 mL | 0.3307 mL | 0.4134 mL |
| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| Oteromycin; Oteromycin | CFN00129 | 170591-45-4 | C32H41NO3 = 487.68 | 5mg | QQ客服:3257982914 |
| 表儿茶素3-(4-O-甲基)没食子酸酯; Epicatechin 3-O-(4-O-methylgallate) | CFN95784 | 108907-44-4 | C23H20O10 = 456.4 | 5mg | QQ客服:2159513211 |
| 蔗果六糖; 1,1,1,1-Kestohexaose | CFN91617 | 62512-19-0 | C36H62O31 = 990.9 | 5mg | QQ客服:1457312923 |
| Cimiaceroside A; Cimiaceroside A | CFN70310 | 210643-83-7 | C35H54O9 = 618.8 | 5mg | QQ客服:2056216494 |